cyc 202 has been researched along with Cystic Fibrosis of Pancreas in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Berre, RL; Chiron, R; Danner-Boucher, I; Durieu, I; Fajac, I; Hery-Arnaud, G; Hillion, S; Hubert, D; Huge, S; Leroy, S; Leven, C; Macey, J; Meijer, L; Mottier, D; Murris-Espin, M; Nowak, E; Prevotat, A; Rault, G; Ravoninjatovo, B; Renaudineau, Y; Urban, T | 1 |
| Elie, J; Häfner, S; Kopp, BT; Meijer, L; Shrestha, CL; Wisniewski, B; Zhang, S | 1 |
| De Rose, V; Ghigo, A; Prono, G; Riccardi, E | 1 |
| Burgel, PR; Marteyn, BS; Meijer, L; Witko-Sarsat, V | 1 |
| Becq, F; Dorothée, G; Gabdoulkhakova, AG; Galons, H; Gray, RD; Gueganton, L; Hall, B; Hery-Arnaud, G; Kulkarni, AB; Le Berre, R; Loaëc, N; Meijer, L; Mottier, D; Nelson, DJ; Norez, C; Nowak, E; Oumata, N; Prochazkova, M; Rault, G; Ravel, D; Riazanski, V; Rossi, AG; Witko-Sarsat, V | 1 |
| Witko-Sarsat, V | 1 |
| Lenoir, G; Moriceau, S; Witko-Sarsat, V | 1 |
3 review(s) available for cyc 202 and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
Dysfunctional Inflammation in Cystic Fibrosis Airways: From Mechanisms to Novel Therapeutic Approaches.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Cannabinoids; COVID-19; COVID-19 Drug Treatment; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Eicosanoids; Humans; Inflammation; Protein Kinase Inhibitors; Roscovitine; Signal Transduction; Thymalfasin | 2021 |
Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
Topics: Animals; Anti-Bacterial Agents; Apoptosis; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Hypoxia; Immunity, Innate; Infections; Inflammation; Lung; Lung Diseases; Macrophages; Mice; Neutrophils; Pseudomonas aeruginosa; Pseudomonas Infections; Purines; Roscovitine; Virulence | 2017 |
Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis.
Topics: Adaptive Immunity; Analgesics; Animals; Anti-Inflammatory Agents; Clinical Trials as Topic; Cystic Fibrosis; Humans; Immunity, Innate; Immunomodulation; Neoplasms; Pain; Purines; Roscovitine | 2016 |
1 trial(s) available for cyc 202 and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
Safety and pharmacokinetics of Roscovitine (Seliciclib) in cystic fibrosis patients chronically infected with Pseudomonas aeruginosa, a randomized, placebo-controlled study.
Topics: Animals; Cystic Fibrosis; Double-Blind Method; Humans; Protein Kinase Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Quality of Life; Roscovitine | 2022 |
3 other study(ies) available for cyc 202 and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
(R)-Roscovitine and CFTR modulators enhance killing of multi-drug resistant Burkholderia cenocepacia by cystic fibrosis macrophages.
Topics: Adolescent; Adult; Burkholderia cenocepacia; Cysteamine; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Therapy, Combination; Female; Humans; Macrophages; Male; Phagocytosis; Pseudomonas aeruginosa; Roscovitine; Young Adult | 2020 |
From Starfish Oocytes to Inflammation: The Unforeseeable Destiny of Roscovitine in Cystic Fibrosis.
Topics: Animals; Cystic Fibrosis; Inflammation; Oocytes; Purines; Roscovitine; Starfish | 2016 |
In cystic fibrosis homozygotes and heterozygotes, neutrophil apoptosis is delayed and modulated by diamide or roscovitine: evidence for an innate neutrophil disturbance.
Topics: Adolescent; Apoptosis; Bacterial Infections; Benzoates; Caspase 3; Child; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Diamide; Female; Heterozygote; Homozygote; Humans; Male; Neutrophils; Oxidation-Reduction; Purines; Roscovitine; Thiazolidines | 2010 |